|
|
|
|
| LEADER |
00000cam a2200000Ia 4500 |
| 001 |
11654986 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
180520s2018 sz a ob 001 0 eng d |
| 005 |
20240711203143.6 |
| 015 |
|
|
|a GBB8O3522
|2 bnb
|
| 016 |
7 |
|
|a 019182985
|2 Uk
|
| 019 |
|
|
|a 1037005970
|a 1040615303
|a 1042885234
|a 1047664134
|a 1048270466
|a 1055324634
|a 1059246583
|a 1086454331
|a 1097103184
|a 1113399279
|a 1117025943
|a 1122847397
|a 1125686660
|a 1136258514
|a 1160068822
|
| 020 |
|
|
|a 9783319732695
|q (electronic bk.)
|
| 020 |
|
|
|a 3319732692
|q (electronic bk.)
|
| 020 |
|
|
|z 3319732684
|
| 020 |
|
|
|z 9783319732688
|
| 024 |
7 |
|
|a 10.1007/978-3-319-73269-5
|2 doi
|
| 035 |
|
|
|a (OCoLC)1036732041
|z (OCoLC)1037005970
|z (OCoLC)1040615303
|z (OCoLC)1042885234
|z (OCoLC)1047664134
|z (OCoLC)1048270466
|z (OCoLC)1055324634
|z (OCoLC)1059246583
|z (OCoLC)1086454331
|z (OCoLC)1097103184
|z (OCoLC)1113399279
|z (OCoLC)1117025943
|z (OCoLC)1122847397
|z (OCoLC)1125686660
|z (OCoLC)1136258514
|z (OCoLC)1160068822
|
| 035 |
|
9 |
|a (OCLCCM-CC)1036732041
|
| 037 |
|
|
|a com.springer.onix.9783319732695
|b Springer Nature
|
| 040 |
|
|
|a YDX
|b eng
|e pn
|c YDX
|d N$T
|d GW5XE
|d EBLCP
|d AZU
|d UAB
|d OCLCF
|d OCLCQ
|d UPM
|d MERER
|d VT2
|d OCLCQ
|d DKU
|d U3W
|d OCLCQ
|d LVT
|d CNCEN
|d WYU
|d UKMGB
|d CAUOI
|d LEAUB
|d OCLCQ
|d ADU
|d LEATE
|d UKAHL
|d OCLCQ
|
| 049 |
|
|
|a MAIN
|
| 050 |
|
4 |
|a RC600
|
| 072 |
|
7 |
|a MED
|x 044000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 038000
|2 bisacsh
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MJF
|2 bicssc
|
| 245 |
0 |
0 |
|a Immune hematology :
|b diagnosis and management of autoimmune cytopenias /
|c Jenny M. Despotovic, editor.
|
| 260 |
|
|
|a Cham, Switzerland :
|b Springer,
|c ©2018.
|
| 300 |
|
|
|a 1 online resource :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Intro; Preface; Contents; Contributors; Part I: Immune Thrombocytopenia (ITP); Chapter 1: Background of Immune Thrombocytopenia; Introduction; Historical Perspective; Terminology; Presentation; Primary ITP and Secondary ITP; Differential Diagnosis; Conclusion; References; Chapter 2: Pathophysiology of Immune Thrombocytopenia; Platelet Autoantibodies; Balance of Platelet Destruction and Production; Abnormal Megakaryocyte Morphology; Antibody Destruction of Megakaryocytes; Inadequate Thrombopoietin Levels; T Cell-Mediated ITP; T Cell-Propagated Autoantibody Production; Helper T Cell Responses.
|
| 505 |
8 |
|
|a Role of Th17 CellsRegulatory T cells; B Cell-Mediated ITP; B-Regulatory Cells; Myeloid-Derived Suppressor Cells; Genetic Studies; Secondary ITP; Helicobacter pylori-Related ITP; CMV-Related ITP; Varicella Zoster-Related ITP; Hepatitis C-Related ITP; HIV-Related ITP; Malignancy-Related ITP; Other Autoimmune Disorders; Evans Syndrome; Autoimmune Lymphoproliferative Syndrome (ALPS); References; Chapter 3: Presentation and Evaluation of Immune Thrombocytopenia; Introduction; Clinical Presentation; History; Physical Examination; Bleeding Assessment; Initial Diagnostic Investigations.
|
| 505 |
8 |
|
|a Diagnostic ApproachAdditional Testing for Suspected ITP; The Role of Bone Marrow Testing; Platelet Antibody Testing; Screening Tests for Associated Conditions; Infectious Triggers for ITP: Hepatitis C, HIV, and H. pylori; Autoimmune Conditions; Immunodeficiencies; Summary; References; Chapter 4: The Treatment of Immune Thrombocytopenia; Introduction; General Treatment Considerations; Who Should Be Treated?; First-Line Management; Corticosteroids; Mechanism of Action; Steroid Treatment Recommendations; Intravenous Immunoglobulin; Mechanism of Action; IVIG Treatment Recommendations.
|
| 505 |
8 |
|
|a Anti-D ImmunoglobulinMechanism of Action; Anti-D Treatment Recommendations; Second-Line Therapy; Splenectomy; Mechanism of Action; Splenectomy Treatment Recommendations; Rituximab; Mechanism of Action; Rituximab Treatment Recommendations; Thrombopoietin Receptor Agonists (TPO-RAs); Mechanism of Action; TPO-RA Adverse Effects; Treatment Recommendations; Use of TPO-RAs in Pediatric ITP; Use of TPO-RAs in Newly Diagnosed ITP; Management of Life-Threatening Bleeding; Other Agents; Antimetabolites; Novel Therapies; References; Part II: Autoimmune Hemolytic Anemia (AIHA).
|
| 505 |
8 |
|
|a Chapter 5: Background, Presentation and Pathophysiology of Autoimmune Hemolytic AnemiaHistory of Immune Hemolysis; Definitions and Classification; Warm AIHA; Pathophysiology; Clinical Features; Cold AIHA (Cold Agglutinin Disease); Pathophysiology; Clinical Features; Paroxysmal Cold Hemoglobinuria; Pathophysiology; Clinical Features; Mixed AIHA; References; Chapter 6: Treatment of Autoimmune Hemolytic Anemia; Introduction; Diagnosis and Classification; Etiology; Frontline Treatment; Blood Transfusions; Corticosteroids; Second-Line Treatments; Rituximab; Splenectomy; Immunosuppressive Therapies.
|
| 520 |
|
|
|a This text provides a concise yet comprehensive overview of the most common autoimmune cytopenias affecting adults and children. The book is divided into four sections, each of which focuses on a major autoimmune cytopenia. The first section features background, pathophysiology, presentation, evaluation, and treatment strategies for immune thrombocytopenia (ITP), the most common cause of antibody-mediated platelet destruction. The second section reviews common forms and treatment strategies for autoimmune hemolytic anemia (AIHA), including a chapter dedicated specifically to Evans Syndrome. The third section comprehensively reviews the pathophysiology, diagnosis and current management approaches to thrombotic thrombocytopenic purpura (TTP), a potentially life-threatening autoimmune syndrome. The book concludes with a final section on autoimmune neutropenia. Each section includes a review of common underlying systemic autoimmune conditions and immune deficiency syndromes that can accompany or cause autoimmune cytopenias. Written by experts in each content area, Immune Hematology: Diagnosis and Management of Autoimmune Cytopenias is a valuable resource for clinicians and professionals who treat patients afflicted with autoimmune cytopenias, including primary care providers, hematologist/oncologists, immunologists, among others.
|
| 650 |
|
0 |
|a Autoimmune diseases
|x Diagnosis.
|
| 650 |
|
0 |
|a Immunology.
|0 http://id.loc.gov/authorities/subjects/sh85064579
|
| 650 |
|
0 |
|a Hematology.
|0 http://id.loc.gov/authorities/subjects/sh85060130
|
| 650 |
|
7 |
|a Oncology.
|2 bicssc
|
| 650 |
|
7 |
|a Haematology.
|2 bicssc
|
| 650 |
|
7 |
|a MEDICAL
|x Immunology.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Hematology.
|2 bisacsh
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a Autoimmune diseases
|x Diagnosis.
|2 fast
|0 (OCoLC)fst00822666
|
| 650 |
|
7 |
|a Hematology.
|2 fast
|0 (OCoLC)fst00954904
|
| 650 |
|
7 |
|a Immunology.
|2 fast
|0 (OCoLC)fst00968006
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Despotovic, Jenny M.
|
| 776 |
0 |
8 |
|i Print version:
|z 3319732684
|z 9783319732688
|w (OCoLC)1013731260
|
| 903 |
|
|
|a HeVa
|
| 929 |
|
|
|a oclccm
|
| 999 |
f |
f |
|i ef5c8cca-cb74-531c-873f-a63de77675b7
|s c3ba70fd-9d07-580d-a732-7c578ea625cf
|
| 928 |
|
|
|t Library of Congress classification
|a RC600
|l Online
|c UC-FullText
|u https://link.springer.com/10.1007/978-3-319-73269-5
|z Springer Nature
|g ebooks
|i 12553607
|
